ARGOS THERAPEUTICS INC 4
4 · ARGOS THERAPEUTICS INC · Filed Jul 1, 2016
Insider Transaction Report
Form 4
Birner Hubert
Director10% Owner
Transactions
- Purchase
Common Stock Warrants (right to buy)
2016-06-29+206,659→ 206,659 total(indirect: See footnote)Exercise: $5.35From: 2016-06-29Exp: 2021-06-29→ Common Stock (206,659 underlying) - Purchase
Common Stock
2016-06-29+275,545→ 1,930,333 total(indirect: See footnote)
Footnotes (2)
- [F1]The reported securities are included within Units purchased by the Reporting Person for $5.44375 per Unit. Each Unit consists of one share of common stock and one warrant to purchase 0.75 shares of common stock.
- [F2]The reported securities are directly held by TVM V Life Science Ventures GmbH & Co. KG ("TVM V"), the managing limited partner of which is TVM V Life Science Ventures Management GmbH & Co. KG ("TVM V Management"), for which the Reporting Person, Stefan Fischer ("Fischer"), Alexandra Goll ("Goll") and Axel Polack ("Polack"), each a member of the investment committee of TVM V Management, share voting and investment authority over the securities held by TVM V. Each of TVM V Management, the Reporting Person, Fischer, Goll and Polack disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, if any.